Nmims India Pharma Market

download Nmims India Pharma Market

of 36

Transcript of Nmims India Pharma Market

  • 7/29/2019 Nmims India Pharma Market

    1/36

    IndianPharmaceutical Market

  • 7/29/2019 Nmims India Pharma Market

    2/36

    Dimensions of the Pharmaceutical Market

    Demographic: geographical & shared socio-economic traits

    Generic: generic equivalents present in a number of

    formulations eg. Erythromycin

    Therapeutic Group: aimed at relieving, treating and curingthe same symptoms of diseases

    eg. Anti-diabetic therapeutic group

    Competitive: extent of competition in terms of numbers,

    their MS & growth rate

    Timing: introduce at the right time, preferably become the

    prime movers (Torrent: 1983-88 grew at avg.182%

    moved from Rk 81 to Rk 36 & in 1992 Rk 13)

  • 7/29/2019 Nmims India Pharma Market

    3/36

    Segments of the Pharmaceutical Market

    Consumer Market: prescription market

    Institutional Market: large hospitals & medical colleges

    Industrial Market: bulk drugs used in formulations

  • 7/29/2019 Nmims India Pharma Market

    4/36

    Criteria for Effective Segmentation

    Measurability: number of members, growing or de-growing

    Accessibility: must be reachable in a cost effective manner

    Desirability: must be large enough to service profitably

    Homogeneity:ensure Fit between the Need profile of

    the segment and the Satisfaction qualities or

    attributes of the product

    Vulnerability: must not be excessively vulnerable to competition

  • 7/29/2019 Nmims India Pharma Market

    5/36

    Four ways of Segmentation

    Demographic factors: age, sex, income, education, stage infamily cycle

    Usage rate: based on usage/consumption pattern

    Perceived product benefits: unearth not-so-apparent benefits

    Psychographic: motive behind the purchase

  • 7/29/2019 Nmims India Pharma Market

    6/36

    Segmentation through Transaction

    Two Major Potential Target Groups

    Patients Doctors(Customers or influencers)(Consumers or end users)

    Similar illness: Diabetic, Asthmatic

    Stage of illness: Acute, Chronic

    Age group: pediatric, Geriatric

    Sex: Male, Female

    Age group: Young, Middle aged, Elderly

    Specialty: Card, Diab, Neuro, Gynec

    Area: Urban, Rural, Hosp, Nrsg. Homes

    Type: Rxing, Dispensing

    Usage: Heavy, Medium, Past, Non-user

  • 7/29/2019 Nmims India Pharma Market

    7/36

    Benefit of Segmentation Strategy

    Helps in focusing promotional effort to

    maximize profits cost-effectively

    Helps in creating a strong positive product-imageTo offset competition

  • 7/29/2019 Nmims India Pharma Market

    8/36

    Key Questions while Segmenting

    1. On what basis?

    Demographic, Geographic, Age group, Sex, Income levels,Therapeutic group, Severity of disease, Product benefits,

    Usage rate, Place of treatment, Specialty

    2. What are the needs of patients?

    3. What are the needs of customers?

    4. Relationship between patients & customers

    5. Is the segment attractive enough?

    6. What is the trend like?

    7. Are there any unsatisfied needs in the segment whichthe product can satisfy?

  • 7/29/2019 Nmims India Pharma Market

    9/36

    Market Dimension

    The size of the geographical market

    State-wise % contribution to all India & Rate of changeIn terms of; Volume, Value & Rx generated

    The size by therapeutic group

    Therapeutic group-wise contribution to the total marketRegion-wise contribution

    In terms of; Volume, Value, Rate of change & Rxs

    The size by demographics of both;

    Patients: number treated, Age, Income, Sex, Location etc

    Doctors: number, age, specialty, location, type of practice

  • 7/29/2019 Nmims India Pharma Market

    10/36

    Market Dimension

    The size of prescription market

    No. of Rxtions written for the therapeutic category

    The size of competition

    Number operating in the segment, Regional shares of the

    total market, Resources, Strengths & Weakness, BenefitPackages offered by major competitors

    The size by volume

    Dealer network according to volume of purchase

    The size of the institutional market by

    Nature, Frequency, Volume, Location, Key people, Criteria

  • 7/29/2019 Nmims India Pharma Market

    11/36

    Served Market Concept

    Is the state-of-the-art of defining market segments andunderstanding market structures-Bruce Henderson (BCG)

    Helps to create a perceptible competitive advantage for

    growth and survival

  • 7/29/2019 Nmims India Pharma Market

    12/36

    Served Market Concept

    Define the total market by size (volume & value), growth

    rate, customer types and competitors

    Define in terms of customer needs and how your product

    can satisfy those needs

    Define your competitors served market in terms of their

    respective customer needs and the competitive advantage

    of their products in satisfying those needs

    Find ways of creating perceptible differentiation and turnit into a distinct competitive advantage

    Communicate with all your might and drive home

    the advantage

  • 7/29/2019 Nmims India Pharma Market

    13/36

    Served Market Concept

    Gelusil v/s Digene(Differentiated thro antiflatulent)

    Pfizer & BE in 70s: PAS, Isoniazid, Thiacetazone & combination

    Lupin in 80s emerged: ethambutol, PZA, RIF

    Sarabhai in 76: narrow spectrum antibiotics & oral penicillinsRanbaxy emerged: broad spectrum semi-synthetic antibiotics

    BE Ltd v/s SII v/s Hoechst: competing in Immunologicals

  • 7/29/2019 Nmims India Pharma Market

    14/36

    Served Market Opportunity Analysis

    1. Strengths of your product in your served market as well as

    in your competitors served market as opposed to their product

    2. Analysis of any possible gaps in customer needs and whether

    the gaps can be exploited profitably

    4. Any possible weaknesses existing in your product offerings ascompared to changing customer needs and the ways in which

    your competitors are responding

    5. Quantitative analysis of the new product in terms of; demand,

    profitability, the edge it would give the companys current

    product-mix, the impact it would have on the existing product-

    mix

    6. Detailed analysis of competitors response to this new segment

  • 7/29/2019 Nmims India Pharma Market

    15/36

    Market Opportunity Analysis

    Step-1

    Analyze your existing market

    What is your directly competing market?

    Step-2

    Build on your strength

    Have you realized all probable opportunities in existing markets?Do SWOT Analysis of your products in all your existing markets

    Are there any unmet needs in your existing markets not fulfilled

    by you and your competitors?

    Are there any major sub-segments where you do not have anyproduct?

    What are the strengths & weakness of your products as

    compared to the competitors-is there need for product devpmt?

    What are the opportunities & threats in your markets?

  • 7/29/2019 Nmims India Pharma Market

    16/36

    Market Opportunity Analysis

    Step-3

    Explore new market opportunities

    List fast growing, largest, less entrenched markets, and

    prioritizethem in order of importance & attractiveness. Also,

    analyze how congruent is the market identified/shortlisted.

    Step-4

    Evaluate new opportunities in new segments

    Is the market large enough and growing rapidly?

    What is the intensity of competition?How does your firm compare with them?

    What is the attribute of your product planned for introduction?

  • 7/29/2019 Nmims India Pharma Market

    17/36

    What Strategic Options?

    1. Concentrated Marketing

    Segmenting the market by customer specialty

    Advantages

    Niche for the company &products

    Provides competitive advantage

    Helps better customer services

    Focuses the resources &optimizes the result

    Disadvantages

    Close monitoring requiredFailure can be devastating

    Segment may not be viable

  • 7/29/2019 Nmims India Pharma Market

    18/36

    What Strategic Options?

    2. Differentiated Marketing

    Marketing to many segments each with differentiated

    marketing-mix

    Advantages

    Minimizes vulnerability factor

    Makes the firm more flexible

    Cost is spread out

    Disadvantages

    Lacks focus

    Cannot achieve dominance

    Diminishing profits

  • 7/29/2019 Nmims India Pharma Market

    19/36

    Positioning: Definition

    Is the battle for space in the consumers mind

    Is less what we do to the product and more what we do to

    the consumers perception of the product

    The positioning of a brand is its perception among targetcustomers

    Is the art of selecting, out of a number of unique selling

    propositions, the one which will get you maximum sales

  • 7/29/2019 Nmims India Pharma Market

    20/36

    Positioning: Definition

    1. The positioning of a brand is the perception it brings aboutIn the mind of a target consumer

    2. This perception reflects the essence of the brand in terms

    of its functional and non-functional benefits in the judgement

    of that consumer

    3. It is relative to the perception, held by that consumer, of

    competing brands, all of which can be represented as points

    or positions in his/her perceptual space and together, makeup a product class

    Thus, positioning creates a unique, credible, sustainable and

    valued place in consumers minds for the brand

  • 7/29/2019 Nmims India Pharma Market

    21/36

    Positioning: Four Components

    1. Product class or the structure of the market in which thebrand will compete

    2. Consumer segmentation

    3. Consumer perception of our brand in relation to competitors,which leads to perceptual mapping

    4. The benefits offered by the brand. These benefits may also

    be expressed as attributes or dimensions along which brandsare fitted to represent consumer judgement

  • 7/29/2019 Nmims India Pharma Market

    22/36

    Positioning:Types

    1.Who Am I?

    Positioning by Parentage/Corporate Identity

    Positioning by Brand Endorsement

    2.What Am I?

    Category Related Positioning

    Benefit Related PositioningPositioning by Usage Occasion & Time

    Price-Quality Positioning

    3.For Whom Am I?

    Demographic Fit

    Behavioral Fit

    Satisfaction Fit

    Psychographic Fit

    The Consumer as a Whole Person

    4.Why Me?

    Positioning by Unique Attribute

    Positioning by Competitor

  • 7/29/2019 Nmims India Pharma Market

    23/36

    Positioning Types Explained

    1.Who Am I?

    Positioning by Parentage/Corporate Identity

    Sony, Tata, HLL, Bajaj, BPL, GSK, Ranbaxy, Unichem

    Positioning by Brand EndorsementCadbury, Ponds, Charminar, Taxim-O

  • 7/29/2019 Nmims India Pharma Market

    24/36

    2.What Am I?

    Category Related

    Milkmaid, Maruti Van, Sugar Free, Alprazolam, Ranitidine

    Benefit RelatedComplan, Pepsodent, Close-Up, Liril, Cardace, Disogel

    Usage Occasion & Time

    Prestige Cooker, Vicks, Burnol, Dettol,Listril, Zentel

    Price-Quality

    Akai, Aiwa, Peter England, Nirma

    Positioning Types Explained

  • 7/29/2019 Nmims India Pharma Market

    25/36

    3.For Whom Am I?

    Demographic FitColgate Kids, Cartoon Network, MTV

    Behavioral Fit

    Lays, Gelusil, Coke

    Satisfaction Fit

    Wills, McDowells No.1, Foster Beer

    Psychographic Fit

    Pepsi, Arrow Shirts, Pulsar

    The Consumer as a Whole Person

    Saffola Wife, J&J Mom, Surf Housewife

    Positioning Types Explained

  • 7/29/2019 Nmims India Pharma Market

    26/36

    4. Why Me?

    Positioning by Unique Attribute

    Dove Soap, Centre Shock, Amron Batteries

    Positioning by CompetitorCaptain Cook Salt v/s Tata Salt, Time Pass v/s Pan Masala

    Savlon v/s Detol, Avis v/s Hertz, Rin Detergent v/s others

    Positioning Types Explained

  • 7/29/2019 Nmims India Pharma Market

    27/36

    Over 8000 Companies, Over 6500 Products

    Doctor meets on an average 10+ Medical Representatives

    exposing 5-8 products

    Daily exposure of 50+ to 80+ products

    Therefore products are ranked in doctors mind

    based on perception

    With the coming down of product differentiation/

    product uniqueness, finding slot in customers mind

    is becoming extremely difficult

    Positioning In Pharma

  • 7/29/2019 Nmims India Pharma Market

    28/36

    1. The type of conditions for which the product will be Rxed

    2. The type of patient for whom the product will be considered

    suitable

    3. The products with which the product will compete closely(Direct & Indirect Competition)

    Positioning and selection of target market (consumer segment)

    are inseparable. A brand must be positioned to appeal to a

    target audience and likewise a target audience too will respond

    to a brand that occupies the position preferred by it.

    Positioning In Pharma: 3 Primary Tasks

  • 7/29/2019 Nmims India Pharma Market

    29/36

    Uniqueness or perceived uniqueness is a products onlyprotection against commodity status. Therefore marketers

    should create a perceivable uniqueness i.e., differential

    advantage.

    A differential advantage should satisfy 3 fundamental criteria;

    1. It should differentiate the product from all other others

    in the product class

    2. It is important or can be made to seem important to thetarget audience

    3. It should be sustainable over time against competition

    Positioning In Pharma: Sustainable

    Differential Advantage

  • 7/29/2019 Nmims India Pharma Market

    30/36

    GriseofulvinGris-OD (American Remedies) v/s Grisovin & Dermonorm

    (IDPL & Glaxo) in anti-fungal market: micronization & OD v/s

    QID

    Ranitidine

    Zantac (Glaxo) v/s Losec (Astra): preemptive campaign to push

    Losec to Reserve Drug status, and also market development

    strategy by expanding usage in non-ulcer dyspepsias,

    gastritis

    Positioning In Pharma

  • 7/29/2019 Nmims India Pharma Market

    31/36

    What position do we already own in the customers mind?

    What position do we want to own?

    What is the Gap like?

    Which companies must be out performed to establish that

    position?

    Does the company have sufficient resources to take thatposition?

    Does the company have the conviction & perseverance?

    Key Questions before Positioning

  • 7/29/2019 Nmims India Pharma Market

    32/36

    1. You cannot appeal to everyoneA product that tries to appeal to everyone winds up appealing

    to no one.

    Eg. Fefol (SKB) & Livogen (Allenburys) v/s others for

    Anaemia in Pregnancy

    Betnelan (Glaxo) in bronchial asthma

    Ground Rules for Positioning

    G f

  • 7/29/2019 Nmims India Pharma Market

    33/36

    2. You cannot beat the brand leaders head-on

    pH4 Biological Evans in Antacid Market (Sodium-free)

    3. You can reposition your brand

    Incidal (Bayer) v/s Avil & Foristal (Hoechst & Ciba Geigy)

    in anti-histamine market: Alert & Daytime Anti-histamine

    Tylenol v/s Aspirin

    Do not mimic another products theme just because ithappens to be a similar product or falls into the same

    product category

    eg. Ridake (Burroughs Wellcome) hyper-critical campaign

    against Aspirinresistance leading to withdrawal of product

    Ground Rules for Positioning

    G d R l f P iti i

  • 7/29/2019 Nmims India Pharma Market

    34/36

    Repositioning of Septran against Tetracycline

    Rs. 40 Mio in 1973 to Rs. 750 Mio in 1992 even when other

    Sulpha drugs de-grew

    4. Aim to occupy Top-7 Rungs in the customers mind

    Unless this happens, there is no chance your brand will

    survive.Because in any product category the few top-brands, usually

    5-7 brands, account for over 90% of the market share.

    If you have a truly new product, tell the customer what the

    product is not, rather than what it is. Because, the mind has

    no room for what is new and different unless it is related to

    the old and matches with prior knowledge.

    Eg. Na Free antacid, Pain-free injection, Non-narcotic cough

    Syrup for children, Non-staining topical ointment etc.

    Ground Rules for Positioning

    G d R l f P iti i

  • 7/29/2019 Nmims India Pharma Market

    35/36

    5. Establish Credibility

    Claiming your product is different is not going to create a

    unique & distinct position. Only when the difference isperceived by the customers, will the product gain acceptance.

    Ground Rules for Positioning

  • 7/29/2019 Nmims India Pharma Market

    36/36

    Thank You